O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1
- 1 March 2004
- journal article
- review article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 96 (3) , 1173-1177
- https://doi.org/10.1152/japplphysiol.00770.2003
Abstract
The cardiovascular and respiratory systems play key roles in O2 homeostasis. Physiological responses to hypoxia involve changes in gene expression that are mediated by the transcriptional activator hypoxia-inducible factor (HIF)-1. Analysis of mice heterozygous for a knockout allele at the locus encoding the O2-regulated HIF-1α or HIF-2α subunit has revealed that these proteins are required for multiple physiological responses to chronic hypoxia, including erythrocytosis and pulmonary vascular remodeling. In mice with partial HIF-2α deficiency, hypoxia-induced expression of endothelin-1 and norepinephrine is dramatically impaired, and the mice fail to develop pulmonary hypertension after 4 wk of exposure to 10% O2. In mice with partial HIF-1α deficiency, the ability of the carotid body to sense and/or respond to acute or chronic hypoxia is lost. In wild-type mice, brief episodes of intermittent hypoxia are sufficient to induce production of erythropoietin (EPO), which protects the heart against apoptosis after ischemia-reperfusion, whereas in mice with partial HIF-1α deficiency, intermittent hypoxia does not induce EPO production or cardiac protection. Parenteral administration of EPO to rodents is sufficient to induce dramatic protection against ischemia-reperfusion injury in the heart. Thus HIF-1 mediates critical physiological responses to hypoxia, and the elucidation of these homeostatic mechanisms may lead to novel therapies for the most common causes of mortality in the US population.Keywords
This publication has 53 references indexed in Scilit:
- Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion InjuryCirculation, 2003
- Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humansThe Journal of Physiology, 2003
- Heterozygous deficiency of hypoxia-inducible factor–2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxiaJournal of Clinical Investigation, 2003
- Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodelingProceedings of the National Academy of Sciences, 2003
- Erratum: Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature miceNature Medicine, 2002
- Erythropoietin crosses the blood–brain barrier to protect against experimental brain injuryProceedings of the National Academy of Sciences, 2000
- Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brainAnnals of Neurology, 2000
- Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesisNature, 1998
- Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in ratsJournal of Applied Physiology, 1995
- Tolerance of the developing heart to ischemia: impact of hypoxemia from birthAmerican Journal of Physiology-Heart and Circulatory Physiology, 1995